Source: Virtual Congress 2020 – Clinical data and COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Ottaviani (Pavia (PV), Italy), B. Balbi (Veruno (NO), Italy), V. Barzon (Pavia (PV), Italy), A. Balderacchi (Pavia (PV), Italy), A. Corino (Pavia (PV), Italy), D. Piloni (Pavia (PV), Italy), F. Mariani (Pavia (PV), Italy), A. Corsico (Pavia (PV), Italy), I. Ferrarotti (Pavia (PV), Italy). Different clinical suspect that brings to the diagnosis of alpha1-antitrypsin deficiency. 995

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Clinical phenotype of individuals with common COPD investigated during the targeted detection programme for alpha1-antitrypsin deficiency in Italy Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Comparison of different algorithms in laboratory diagnosis of Alpha1-antitripsin deficiency Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe dyspnea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Patients with Alpha-1 antitrypsin Deficiency due to Null mutations have clinical peculiarities and should require personalized pulmonary management Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients Source: Eur Respir J 2015; 46: 197-206 Year: 2015 a1-antitrypsin PI*SZ genotype: a SERPINA1 deficiency haplotype with uncertain clinical and therapeutic implications Source: Eur Respir J, 55 (6) 2000713; 10.1183/13993003.00713-2020 Year: 2020 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency? Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Family screening in alpha1-antitrypsin deficiency Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Current and future therapy of lung emphysema caused by alpha-1-antitrypsin deficiency Source: Annual Congress 2004 - Alpha-1-antitrypsin deficiency: Current knowledge and new frontiers Year: 2004 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 What we have learned about alpha-1-antitrypsin deficiency Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020